RHON-KLINIKUM AG Unsponsored ADR

RKAGYOTCHealthcare● Active

$8.16

+$0.00(+0.00%)

Market Cap$1.1B

P/E Ratio—

52W High$8.16

52W Low$7.31

Avg Volume45.064

Open$8.16

Beta-0.00

Earnings Financials Revenue

RHON-KLINIKUM AG Unsponsored ADR (RKAGY) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

RKAGY · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026Report Date: May 6, 2026

EPS Actual

$0.11

Revenue

$0.51B

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 6, 2026

After Market Close

RKAGY reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	May 6, 2026	—	$0.11	—	$0.51B	—	—
— Q1 FY2026	Mar 25, 2026	—	$0.09	—	$0.51B	—	—
— Q3 FY2025	Aug 7, 2025	—	$0.06	—	$0.49B	—	—
— Q2 FY2025	May 8, 2025	—	$0.12	—	$0.45B	—	—
— Q1 FY2025	Mar 27, 2025	—	$0.23	—	$0.44B	—	—
— Q4 FY2024	Nov 7, 2024	—	$0.16	—	$0.43B	—	—
— Q3 FY2024	Aug 8, 2024	—	$0.15	—	$0.49B	—	—
— Q2 FY2024	May 8, 2024	—	$0.17	—	$0.41B	—	—

Q2 FY2026

May 6, 2026

EPS Actual

$0.11

EPS Est.

—

EPS Surpr.

—

Revenue

$0.51B

Q1 FY2026

Mar 25, 2026

EPS Actual

$0.09

EPS Est.

—

EPS Surpr.

—

Revenue

$0.51B

Q3 FY2025

Aug 7, 2025

EPS Actual

$0.06

EPS Est.

—

EPS Surpr.

—

Revenue

$0.49B

Q2 FY2025

May 8, 2025

EPS Actual

$0.12

EPS Est.

—

EPS Surpr.

—

Revenue

$0.45B

Q1 FY2025

Mar 27, 2025

EPS Actual

$0.23

EPS Est.

—

EPS Surpr.

—

Revenue

$0.44B

Q4 FY2024

Nov 7, 2024

EPS Actual

$0.16

EPS Est.

—

EPS Surpr.

—

Revenue

$0.43B

Q3 FY2024

Aug 8, 2024

EPS Actual

$0.15

EPS Est.

—

EPS Surpr.

—

Revenue

$0.49B

Q2 FY2024

May 8, 2024

EPS Actual

$0.17

EPS Est.

—

EPS Surpr.

—

Revenue

$0.41B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	May 6, 2026	—	$8.16	$8.16	+0.00%
— Q1 FY2026	Mar 25, 2026	—	$8.16	$8.16	+0.00%
— Q3 FY2025	Aug 7, 2025	—	$7.37	$7.37	+0.00%
— Q2 FY2025	May 8, 2025	—	$7.85	$7.85	+0.00%
— Q1 FY2025	Mar 27, 2025	—	$6.05	$6.05	+0.00%
— Q4 FY2024	Nov 7, 2024	—	$6.05	$6.05	+0.00%
— Q3 FY2024	Aug 8, 2024	—	$6.05	$6.05	+0.00%
— Q2 FY2024	May 8, 2024	—	$6.05	$6.05	+0.00%

Q2 FY2026+0.00%

Report Date

May 6, 2026

EPS Beat/Miss

—

Price Before

$8.16

Price After

$8.16

Q1 FY2026+0.00%

Report Date

Mar 25, 2026

EPS Beat/Miss

—

Price Before

$8.16

Price After

$8.16

Q3 FY2025+0.00%

Report Date

Aug 7, 2025

EPS Beat/Miss

—

Price Before

$7.37

Price After

$7.37

Q2 FY2025+0.00%

Report Date

May 8, 2025

EPS Beat/Miss

—

Price Before

$7.85

Price After

$7.85

Q1 FY2025+0.00%

Report Date

Mar 27, 2025

EPS Beat/Miss

—

Price Before

$6.05

Price After

$6.05

Q4 FY2024+0.00%

Report Date

Nov 7, 2024

EPS Beat/Miss

—

Price Before

$6.05

Price After

$6.05

Q3 FY2024+0.00%

Report Date

Aug 8, 2024

EPS Beat/Miss

—

Price Before

$6.05

Price After

$6.05

Q2 FY2024+0.00%

Report Date

May 8, 2024

EPS Beat/Miss

—

Price Before

$6.05

Price After

$6.05

Beat Rate0 / 8 quarters

Largest Move+0.00% (Q2 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

RHON-KLINIKUM AG Unsponsored ADR (RKAGY) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.11 (in line with the analyst consensus of —). The next RKAGY earnings date is expected around September 1, 2026.

Each quarter, investors track RKAGY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RKAGY revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

RKAGY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

RKAGY earnings · 4 questions

RHON-KLINIKUM AG Unsponsored ADR's next earnings report is expected around September 1, 2026. RKAGY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RKAGY historically reports after market close (AMC).

RKAGY earnings datewhen is RKAGY earningsRKAGY next earnings datewhen does RKAGY report earningsRKAGY earnings calendar

▸ Source: FMP · RHON-KLINIKUM AG Unsponsored ADR SEC filings · US GAAP · RHON-KLINIKUM AG Unsponsored ADR SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026